DocuSign’s results reflect a sequential decline in the $300K+ customer cohort, one analyst says. The addition of GenAI to the company’s product portfolio may bring more opportunities in the pipeline, ...
Investors are disappointed with the second RIF restructuring not flowing to margins, one analyst said. The new CEO’s greater emphasis on product innovation will be a welcome development, another ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results